Superior and Sustained Performance: Arthramid achieves 80-85% efficacy across multiple peer-reviewed studies Long-lasting Results: Clinical studies demonstrate sustained efficacy up to 2 years post-treatment Evidence-Based Efficacy: Double-blinded controlled studies confirm Arthramid outperforms triamcinolone steroid and hyaluronic acid Proven Safety Profile: Histopathology studies confirm successful joint integration and biocompatibility Robust Research Foundation: Results validated across six independent peer-reviewed studies spanning multiple research teams and geographical locations Unlike many joint treatments on the market, Arthramid is backed by a growing body of robust, real-world research, not just anecdotal outcomes
Patients can opt for cheaper versions of these drugs that are made by compounding pharmacies, but they can be unreliable and unsafe
What a dietitian wants you to know about Ro Body We asked Kelli McGrane, MS, RD, for her thoughts on Ro Body
Possible Ozempic Side Effects: Blood Clots, DVTs, and Pulmonary Embolisms The meta-analysis published in the Endocrine Journal found a 266% increased risk of developing a specific type of blood clot called a DVT
The buyer has ruled out prescription GLP-1 therapy or isn't a candidate for it, and wants a plant-based supplement option to complement a healthy diet and active lifestyle
